(VIANEWS) – Fabrinet Ordinary Shares (FN), Boston Scientific (BSX), K12 (LRN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Fabrinet Ordinary Shares (FN)
12.3% sales growth and 16.98% return on equity
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing. Its products include switching products, including reconfigurable optical add-drop multiplexers, optical amplifiers, modulators, and other optical components and modules that enable network managers to route voice, video, and data communications traffic through fiber optic cables at various wavelengths, speeds, and over various distances. The company's products also comprise tunable lasers, transceivers, and transponders; and active optical cables, which provide high-speed interconnect capabilities for data centers and computing clusters, as well as Infiniband, Ethernet, fiber channel, and optical backplane connectivity. In addition, it provides solid state, diode-pumped, gas, and fiber lasers used in semiconductor processing, biotechnology and medical device, metrology, and material processing industries; and differential pressure, micro-gyro, fuel, and other sensors used in automobiles, as well as non-contact temperature measurement sensors for the medical industry. Further, the company designs and fabricates application-specific crystals, lenses, prisms, mirrors, laser components, and substrates; and other custom and standard borosilicate, clear fused quartz, and synthetic fused silica glass products. It serves original equipment manufacturers of optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company was incorporated in 1999 and is based in George Town, the Cayman Islands.
Earnings Per Share
As for profitability, Fabrinet Ordinary Shares has a trailing twelve months EPS of $6.93.
PE Ratio
Fabrinet Ordinary Shares has a trailing twelve months price to earnings ratio of 23.73. Meaning, the purchaser of the share is investing $23.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.98%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.6%, now sitting on 2.72B for the twelve trailing months.
Yearly Top and Bottom Value
Fabrinet Ordinary Shares’s stock is valued at $164.45 at 11:22 EST, way below its 52-week high of $229.02 and way higher than its 52-week low of $90.19.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 8.8% and 16.7%, respectively.
2. Boston Scientific (BSX)
9.2% sales growth and 8.58% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $1.07.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 63.62. Meaning, the purchaser of the share is investing $63.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.58%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 8.5% and 5.7%, respectively.
Sales Growth
Boston Scientific’s sales growth is 8.7% for the current quarter and 9.2% for the next.
3. K12 (LRN)
9.1% sales growth and 18.2% return on equity
K12 Inc., a technology-based education company, provides proprietary and third-party online curriculum, software systems, and educational services to facilitate individualized learning for students primarily in kindergarten through 12th grade (K-12) in the United States and internationally. The company offers managed public school programs, which offer an integrated package of systems, services, products, and professional services that K12 administers to support an online or blended public school, including administrative support, information technology and provisioning, academic support, curriculum, learning systems, and instructional services. It also provides institutional–non-managed public school programs, which offers instruction, curriculum, supplemental courses, marketing, enrollment, and other educational services; and institutional software and services, such as educational software and services to school districts, public schools, and other educational institutions. In addition, the company offers private pay schools and other services; and talent development services for individuals and enterprises in information technology fields. Further, it provides curriculum portfolios, pre-K and K-8 courses, high school courses, learning applications, and learning management systems; and TotalView, a student information system, which include a suite of online applications that offers administrators, teachers, parents, and students a view of student attendance, truancy management, graduation planning, communications, and learning kit shipment tracking. Additionally, the company provides a suite of services, such as academic support, and administrative and technology to students and their families, as well as directly to virtual and blended public schools, traditional schools, and school districts. It sells individual K-8 online courses and supplemental educational products directly to families. K12 Inc. was founded in 2000 and is headquartered in Herndon, Virginia.
Earnings Per Share
As for profitability, K12 has a trailing twelve months EPS of $3.97.
PE Ratio
K12 has a trailing twelve months price to earnings ratio of 14.66. Meaning, the purchaser of the share is investing $14.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.2%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 10% and 13.9%, respectively.
Volume
Today’s last reported volume for K12 is 1056270 which is 38.75% above its average volume of 761251.
Yearly Top and Bottom Value
K12’s stock is valued at $58.20 at 11:22 EST, way under its 52-week high of $69.70 and way above its 52-week low of $35.61.
Sales Growth
K12’s sales growth for the next quarter is 9.1%.
4. Grand Canyon Education (LOPE)
6% sales growth and 30.24% return on equity
Grand Canyon Education, Inc. provides education services to colleges and universities in the United States. The company's technology services include learning management system, internal administration, infrastructure, and support services; academic services comprises program and curriculum, faculty and related training and development, class scheduling, and skills and simulation lab sites; and counseling services and support include admission, financial aid, and field experience and other counseling services. It also offers marketing and communication services, such as lead acquisition, digital communications strategy, brand identity, market research, media planning and strategy, video, and business intelligence and data science; and back-office services comprising finance and accounting, human resources, audit, and procurement services. The company supports healthcare education programs for 27 universities. Grand Canyon Education, Inc. was founded in 1949 and is based in Phoenix, Arizona.
Earnings Per Share
As for profitability, Grand Canyon Education has a trailing twelve months EPS of $6.8.
PE Ratio
Grand Canyon Education has a trailing twelve months price to earnings ratio of 19.44. Meaning, the purchaser of the share is investing $19.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.24%.
